Phillip B Moheno

US Patent:

20080166355, Jul 10, 2008

Filed:

Oct 30, 2007

Appl. No.:

11/981398

Inventors:

Phillip Moheno - La Jolla CA, US
Wolfgang Pfleiderer - Konstanz, DE

Assignee:

SanRx Pharmaceuticals, Inc. - La Jolla CA

International Classification:

A61K 39/395
C07D 475/00
A61K 35/12
A61P 31/00
A61P 35/00
A61K 31/4985

US Classification:

4241411, 544258, 514249, 424 937

Abstract:

Provided herein is dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon. Also provided herein is the compound dipterinyl calcium pentahydrate (DCP) or an analog or polymorph thereof.

US Patent:

20100105692, Apr 29, 2010

Filed:

Dec 21, 2009

Appl. No.:

12/643752

Inventors:

Phillip Moheno - La Jolla CA, US
Wolfgang Pfleiderer - Konstanz, DE

International Classification:

A61K 31/4985
A61P 31/00
A61P 35/00
A61P 37/00

US Classification:

514249

Abstract:

Provided herein is dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon. Also provided herein is the compound dipterinyl calcium pentahydrate (DCP) or an analog or polymorph thereof.

US Patent:

20120251495, Oct 4, 2012

Filed:

Jan 16, 2009

Appl. No.:

13/384583

Inventors:

Phillip Moheno - La Jolla CA, US
Wolfgang Pfleiderer - Konstanz, DE
Antonio DiPasquale - San Bruno CA, US
Arnold Rheingold - La Jolla CA, US
Dietmar Fuchs - Innsbruck, AT

International Classification:

A61K 31/519
A61K 39/395
A61K 38/21
A61K 31/675
A61K 31/522
A61K 31/7072
A61P 35/00
A61P 35/02
A61P 37/02
A61P 29/00
A61P 31/00
A61P 25/28
A61P 25/00
A61P 3/04
A61P 9/00
A61P 3/10
A61P 9/10
A61P 25/16
A61P 19/02
A61P 17/06
A61P 19/04
A61P 11/00
A61P 11/06
A61P 13/12
A61P 1/00
A61P 37/06
A61P 1/04
A61N 5/10
A61K 35/12

US Classification:

424 857, 514249, 424 937, 4241411, 4242781, 514 81, 514 50, 600 1

Abstract:

Disclosed herein are methods for the treatment of cancer and inflammatory-based diseases and disorders, such as hepatitis B virus infection based upon the administration of calcium pterin. In one embodiment is a method of treating cancer comprising administration of dipterinyl calcium pentahydrate (DCP). In another embodiment is a method of treating hepatitis B virus infection comprising administration of dipterinyl calcium pentahydrate (DCP).

US Patent:

20170143720, May 25, 2017

Filed:

Nov 16, 2016

Appl. No.:

15/353527

Inventors:

- La Jolla CA, US
Phillip Moheno - San Diego CA, US

International Classification:

A61K 31/519
A61K 45/06

Abstract:

Disclosed herein are methods for the treatment of cancer and inflammatory-based diseases and disorders, such as hepatitis B virus infection, tuberculosis and type 2 diabetes based upon the administration of CaFolate. In one embodiment is a method of treating cancer comprising administration of CaFolate. In another embodiment is a method of treatment inflammatory-based disease and disorders comprising administration of CaFolate.

US Patent:

20160015711, Jan 21, 2016

Filed:

Jun 24, 2015

Appl. No.:

14/749532

Inventors:

- La Jolla CA, US
Phillip B.B. MOHENO - San Diego CA, US

International Classification:

A61K 31/519
A61K 31/167

Abstract:

Provided herein are methods of treating an inflammatory-based disease or disorder in a subject by administering a composition comprising CaPterin-6-COOH.

US Patent:

20150010509, Jan 8, 2015

Filed:

Jan 29, 2013

Appl. No.:

14/375411

Inventors:

- La Jolla CA, US
Phillip Moheno - San Diego CA, US

Assignee:

SanRx Pharmaceuticals, Inc. - La Jolla CA

International Classification:

A61K 31/519
A61K 45/06

US Classification:

424 857, 514250, 4241411, 424 937, 514 81, 514 50, 514 61, 514 23, 5142302

Abstract:

Disclosed herein are methods for the treatment of cancer and inflammatory-based diseases and disorders, such as hepatitis B virus infection, tuberculosis and type 2 diabetes based upon the administration of CaFolate. In one embodiment is a method of treating cancer comprising administration of CaFolate. In another embodiment is a method of treatment inflammatory-based disease and disorders comprising administration of CaFolate.